- Home
- FCEL vs NTRB Comparison
FCEL vs NTRB Comparison
Compare FCEL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- NTRB
- Stock Information
- Founded
- FCEL 1969
- NTRB 2016
- Country
- FCEL United States
- NTRB United States
- Employees
- FCEL N/A
- NTRB N/A
- Industry
- FCEL Industrial Machinery/Components
- NTRB Industrial Specialties
- Sector
- FCEL Energy
- NTRB Health Care
- Exchange
- FCEL Nasdaq
- NTRB Nasdaq
- Market Cap
- FCEL 106.2M
- NTRB 87.2M
- IPO Year
- FCEL 1992
- NTRB N/A
- Fundamental
- Price
- FCEL $10.24
- NTRB $7.62
- Analyst Decision
- FCEL Hold
- NTRB Buy
- Analyst Count
- FCEL 5
- NTRB 1
- Target Price
- FCEL $8.13
- NTRB $13.00
- AVG Volume (30 Days)
- FCEL 5.4M
- NTRB 32.7K
- Earning Date
- FCEL 09-09-2025
- NTRB 09-09-2025
- Dividend Yield
- FCEL N/A
- NTRB N/A
- EPS Growth
- FCEL N/A
- NTRB N/A
- EPS
- FCEL N/A
- NTRB N/A
- Revenue
- FCEL $152,472,000.00
- NTRB $2,578,059.00
- Revenue This Year
- FCEL $35.65
- NTRB $560.75
- Revenue Next Year
- FCEL $38.42
- NTRB $588.39
- P/E Ratio
- FCEL N/A
- NTRB N/A
- Revenue Growth
- FCEL 78.81
- NTRB 42.92
- 52 Week Low
- FCEL $3.58
- NTRB $2.98
- 52 Week High
- FCEL $13.98
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- FCEL 73.08
- NTRB 64.09
- Support Level
- FCEL $7.35
- NTRB $6.82
- Resistance Level
- FCEL $11.15
- NTRB $7.94
- Average True Range (ATR)
- FCEL 0.94
- NTRB 0.43
- MACD
- FCEL 0.17
- NTRB 0.09
- Stochastic Oscillator
- FCEL 77.37
- NTRB 86.20
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.